Provided by Tiger Fintech (Singapore) Pte. Ltd.

CNBX Pharmaceuticals Inc.

0.0006
0.0000
Volume:1.36M
Turnover:816.00
Market Cap:55.51K
PE:-0.09
High:0.0006
Open:0.0006
Low:0.0006
Close:0.0006
Loading ...
Jul 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Correspondence

Form CORRESP - Correspondence
Apr 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2024

Correspondence

Form CORRESP - Correspondence
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 30, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]